This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Rick Rogers
Vice President
Contact
RickRogers@z3312.comOverview
Rick Rogers is a Vice President in our Client Technology Solutions (CTS) group. He has more than 25 years of experience leading innovative and high-performing software development teams. His expertise is in developing consensus on the vision for IT projects and communicating it to stakeholders and applying rigorous analysis, coupled with creative thinking, to re-engineer business processes. Rogers directs an IT team in support of the Population Assessment of Tobacco and Health (PATH) Study. This project assesses tobacco use behavior, attitudes, and beliefs, as well as tobacco-related health outcomes throughout the U.S.
Earlier in his career, Rogers worked as the solutions architect for a team that provided cloud-based digital video hosting and storage services. He also collaborated on electronic survey design and led an award-winning business process re-engineering at the U.S. Census Bureau, resulting in significant operational savings. In addition, he created a performance model for the 2010 Decennial Census high-volume imaging operations, mitigating key bottlenecks. He holds 2 patents in the area of archival/digital records.
Education
- MBA (with Honors), General Management, University of Chicago Booth School of Business
- BA (magna cum laude), History, Carleton College
-
Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV
225,
Journal of Infectious Diseases
January 2022
G. Duarte, P. Muresan, S. Ward, L. Laimon, S.I. Pelton, J. Canniff, A. Golner, et al.
DOILink for: Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV -
Depot medroxyprogesterone acetate use and the development and progression of uterine leiomyoma
139,
Obstetrics and Gynecology
January 2022
Q.E. Harmon, S.A. Patchel, S. Zhao, D.M. Umbach, T.E. Cooper, D.D. Baird
DOILink for: Depot medroxyprogesterone acetate use and the development and progression of uterine leiomyoma -
Development, pilot study, and psychometric analysis of the AHRQ Surveys on Patient Safety Culture (SOPS) Workplace Safety Supplemental Items for Hospitals
19,
International Journal of Environmental Research and Public Health
January 2022
K. Zebrak, Naomi Dyer Yount, Joann Sorra, T. Famolaro, Laura C. Gray, D. Carpenter, A. Caporaso
DOILink for: Development, pilot study, and psychometric analysis of the AHRQ Surveys on Patient Safety Culture (SOPS) Workplace Safety Supplemental Items for Hospitals